Peyronie’s disease is a connective tissue condition that affects the penis. It occurs as a result of a scar tissue, also known as plaque, that develops inside the penis. This disease can cause the penis to bend, straight, or erect. This connective tissue disorder forms in the tunica albuginea, a thick sheath, that covers the corpora cavernosa. This causes discomfort, and also an abnormal curvature in the patient. Patients might also develop erectile dysfunction, indentation, loss of girth and shortening. The curvature that occurs in this disease might worsen progressively if not well managed. However, it stabilizes at some point. The pain experienced by patients might improve between the range of one to two years, although the scar tissue and curvature still remain. The mild forms of this disease don’t require treatment, as they tend to go after some time. However, there are forms of Peyronie’s disease that causes a lot of discomfort to the patient. Shockwave therapy is one of the ways of treating this disease.

What Are The Signs And Symptoms Of Peyronie’s Disease?

The signs and symptoms of this disease might develop suddenly or gradually. Below are some of the signs and symptoms of the disease;

What Are The Causes Of Peyronie’s Disease?

The exact cause of this disease isn’t completely understood yet. However, some factors have been identified to be responsible for the development of this disease.

Blood flows to the chambers and vessels of the penis. The penis enlarges, straightens and becomes rigid, as this occurs. A patient that has developed scar tissues or nodules will have a disfigured penis. This might also come with pain.

What Are The Risk Factors Of Peyronie’s Disease?

Apart from injuries, there are other factors that could lead to the development of Peyronie’s disease. However, it’s important to know that minor injuries to the penis don’t always lead to Peyronie’s disease. Factors such as poor wound healing, the accumulation of scar tissues, also play important roles in the development of this disease. Below are the other risk factors associated with Peyronie’s disease;

What Are The Complications Of Peyronie’s Disease?

Peyronie’s disease does have some complications, especially when the disease isn’t well managed.

How Do Physicians Diagnose Peyronie’s Disease?

Physicians diagnose this disease by taking the medical history of the patient. This also performs a physical examination of the patient. The doctor would feel the hardened tissue, during this examination. If the penis has to be erect during the examination, the physician would inject medications that would cause this to happen. Physicians might also carry out a medical imaging test of the penis. This includes X-ray or ultrasound of the penis. Lastly, physicians might also take a biopsy of the penis. They do this by taking a sample of the tissue from the affected area of the penis.

How Is Peyronie’s Disease Treated?

Peyronie’s disease can be treated. However, there have been a lot of cases that resolved without any form of treatment. This is why physicians tend to wait for about 12 to 24 months before trying to correcting the disorder. The mild forms of this disease don’t need any intervention. Although, treatment is needed when the patient complains of pain, and cannot perform sexually.

What Are The Common Treatments Available?

Physicians generally administer medications or surgery. Examples of drugs prescribed by doctors include pentoxifylline or potassium paraminobenzoate. In case these drugs don’t work, physicians might also administer verapamil or collagenase into the scar tissues of the penis. On the other hand, some common operations carried out by doctors include;

References

Bell, D. (2008). Peyronie Disease in Association with Carvedilol: A Case Report. Southern Medical Journal, 101(11), 1157-1158. doi: 10.1097/smj.0b013e3181831441

Groth, T., & Monga, M. (2003). EXTRACORPOREAL SHOCKWAVE THERAPY FOR PEYRONIE DISEASE. Archives Of Andrology, 49(3), 205-213. doi: 10.1080/713828135

Kelâmi, A. (1980). Peyronie disease and surgical treatment. Urology, 15(6), 559-561. doi: 10.1016/0090-4295(80)90365-9